Sign in
4

Changes in Ownership

Xenon Pharmaceuticals Inc. Filed Acc 0001209191-23-021136

Chief Medical Officer sold 700 shares at $35.01 ($24,507)

From the SEC's structured data for this filing

Trades in this filing

KENNEY CHRISTOPHER JOHN · Chief Medical Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-03-24 Sale : show line 1 in the form −700 $35.01 $24,507 0 D
Open-market sales · 700 sh · avg $35.01 · $24,507
Loading xslF345X04/doc4.xml…